Innovating Works

TARTU UNIVERSITY HOSPITAL

Desconocido
SAFEST: Improving quality and patient SAFEty in surgical care through STandardisation and harmonisation of p... SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 Adverse events in health care are suffered by between 8% and 12% of patients admitted to hospitals in the EU and are accountable for around...
2022-05-18 - 2026-05-31 | Financiado
RE-SAMPLE: RE SAMPLE SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un H2020: H2020-SC1-BHC-2018-2020 Multi-morbid complex chronic conditions (CCCs) are highly prevalent in patients with Chronic Obstructive Pulmonary Disease (COPD). As they h...
2021-01-18 - 2025-02-28 | Financiado
HEDIMED: Human Exposomic Determinants of Immune Mediated Diseases SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un H2020: H2020-SC1-BHC-2018-2020 Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challen...
2019-12-06 - 2024-12-31 | Financiado
SZ_TEST: Towards Early Molecular Diagnostics of Schizophrenia SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un H2020: H2020-MSCA-RISE-2016 Schizophrenia (SZ) is a severe mental disorder affecting more than 0.7% of the adult population. One of the most disabling and emotionally d...
2016-12-05 - 2022-06-30 | Financiado
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un H2020: H2020-PHC-2014-2015 Every year, 1.3 million Europeans have a stroke and one million ultimately die of stroke. One third of stroke patients remain dependent on t...
2015-04-07 - 2022-11-30 | Financiado
DIABIMMUNE: Pathogenesis of Type 1 Diabetes Testing the Hygiene Hypothesis SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un FP7: Preliminary data indicate that there is a strong association between the incidence of immune-mediated diseases and improving standard of liv...
Financiado
LIVING DONATION: Living Organ Donation in Europe SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un FP7: The project on living organ donation in Europe is a coordination action that aims to 1) establish an inventory of living donation practices...
Financiado
GAPP: GAbapentin in Paediatric Pain SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un FP7: Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate...
Financiado
TB PAN-NET: Pan European network for the study and clinical management of drug resistant tuberculosis SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un FP7: This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB)...
Financiado
ADHOPHTA: Adopting Hospital Based Health Technology Assessment in EU SIHTASUTUS TARTU ULIKOOLI KLIINIKUM participó en un FP7: The use of HTA as a part of the decision-making process at national, regional, and international levels has evolved considerably over the pa...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.